<unk>  is indicated for the treatment of lead poisoning in children with blood level measured above 45 µg/dl. The use of<unk>  is not approved for prevention of lead poisoning in anticipation of exposure in known lead-contaminated environments.<unk>  can cross the blood–brain barrier of mice, but it is not known if this is also the case in humans. Even if<unk>  cannot reverse the damages done to the central nervous system, it might prevent further deterioration.<unk>  facilitates urinary excretion of lead, and with sufficiently aggressive treatment, can reduce lead content in the brain. It also increases urinary excretion of copper and zinc.<unk>  improved cognitive function in rats that had been exposed to lead, but reduced cognitive function in rats that had not been exposed to lead.
Dimercaptosuccinic acid
Sodium fluoroacetate
Dimercaprol
Mercapturic acid
Dimethyl methylphosphonate
Fomepizole
Disufenton sodium
Sodium azide